<SEC-DOCUMENT>0001558370-23-011374-index.html : 20230623 <SEC-HEADER>0001558370-23-011374.hdr.sgml : 20230623 <ACCEPTANCE-DATETIME>20230623160514 ACCESSION NUMBER: 0001558370-23-011374 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230623 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 231037664 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>sngx-20230623x8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: sngx-20230623x8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>2 <FILENAME>sngx-20230623.xsd <DESCRIPTION>EX-101.SCH <TEXT> Document 2 - file: sngx-20230623.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>3 <FILENAME>sngx-20230623_def.xml <DESCRIPTION>EX-101.DEF <TEXT> Document 3 - file: sngx-20230623_def.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>4 <FILENAME>sngx-20230623_lab.xml <DESCRIPTION>EX-101.LAB <TEXT> Document 4 - file: sngx-20230623_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>5 <FILENAME>sngx-20230623_pre.xml <DESCRIPTION>EX-101.PRE <TEXT> Document 5 - file: sngx-20230623_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>6 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 6 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>7 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 7 - file: R2.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>8 <FILENAME>sngx-20230623x8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: sngx-20230623x8k_htm.html
Document 8 - RAW XML: sngx-20230623x8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>9 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: FilingSummary.html
Document 12 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>15 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>16 <FILENAME>0001558370-23-011374-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: 0001558370-23-011374-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>